(Q80242426)
Statements
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound (English)
Bernard Escudier
Linda Chami
Jérome Leclère
Alain Roche
Nathalie Lassau
11 September 2006